Floatz logo

Romidepsin

Anaplastic Large Cell Lymphoma

Walter HanelSmall moleculePhase 2Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
81/ 100

Competitive context

33 Active assets in the Anaplastic Large Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Inno-206
Children's Cancer Group, China
Phase 4BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BBB
(+)-VINCRISTINE
Seagen Inc.
Phase 4BBB
ETOPOSIDE
City of Hope Medical Center
Phase 4BB
METHOTREXATE
Children's Cancer Group, China
Phase 4BB

View all 50 →

Same molecule, other indications

Romidepsin is also rated in:

Myelodysplastic/Myeloproliferative DiseasesDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Mycosis Fungoides/Sezary SyndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Multiple Myeloma and Plasma Cell NeoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →